Transitioning from Nasogastric to Percutaneous Endoscopic Gastrostomy Tubes

Primary Decision Algorithm: Duration of Feeding Need

The American Society for Parenteral and Enteral Nutrition recommends transitioning from nasogastric (NG) tube to percutaneous endoscopic gastrostomy (PEG) tube when enteral nutrition is anticipated to exceed 4-6 weeks, with a Grade B recommendation and 93% consensus 1, 2
NG tubes are appropriate for patients requiring enteral nutrition for less than 4-6 weeks, according to the Clinical Nutrition guideline 1, 2, 3

PEG tubes have significantly lower rates of intervention failure, including feeding interruption, tube blocking, tube leakage, and poor adherence, with a relative risk of 0.18 (95% CI 0.05-0.59) 1, 2
The risk of tube dislodgement is substantially lower with PEG, with a relative risk of 0.17 (95% CI 0.05-0.58) for self-extubation 1, 2
PEG tubes provide superior quality of life outcomes, including reduced inconvenience, discomfort, improved body image, and better social activities, with relative risks of 0.03, 0.03, 0.01, and 0.01, respectively 1, 2
PEG feeding demonstrates superior nutritional efficacy, with better improvement in weight gain, mid-arm circumference (MD 1.16, 95% CI 1.01-1.31), and serum albumin levels (MD 6.03, 95% CI 2.31-9.74) 1, 2

NG tubes are associated with less dysphagia and earlier weaning after completion of radiotherapy in head and neck cancer patients, according to the Clinical Nutrition guideline 1, 2
Well-tolerated NG tubes can be used for periods longer than 4-6 weeks in selected cases when PEG is not suitable or available, as recommended by the Clinical Nutrition guideline 1, 3
The European Society for Clinical Nutrition and Metabolism (ESPEN) suggests considering PEG placement when inadequate nutrition is expected for 2-3 weeks or longer 4

The European Society for Clinical Nutrition and Metabolism (ESPEN) recommends not using PEG as a substitute for good nursing care or for administrative convenience 4
Proper patient selection is crucial, and PEG placement should be confirmed only after adequate gastrointestinal function and realistic prognosis have been established, as recommended by the Clinical Nutrition guideline 4

For a confused patient who repeatedly pulls out their nasogastric tube, placement of a percutaneous endoscopic gastrostomy (PEG) tube is the definitive solution and should be pursued without delay if enteral nutrition is expected to continue beyond 4 weeks, as recommended by the American Gastroenterological Association 5, 6
PEG tube placement is strongly recommended for this clinical scenario because it directly addresses the core problem of tube dislodgement while providing superior outcomes across multiple domains, with a Grade B recommendation and 93% consensus from the American Gastroenterological Association 5, 6

If enteral nutrition is needed for more than 4 weeks, PEG is the preferred route, with a Grade B recommendation and 93% consensus from the American Gastroenterological Association 5, 6
If enteral nutrition is needed for less than 4 weeks, NG tube remains appropriate only if the patient tolerates it, as recommended by the American Gastroenterological Association 5, 6

Obtain informed consent from a legally authorized representative if the patient lacks capacity, and administer a single dose of first-generation cephalosporin immediately before the procedure to reduce peristomal infection risk, as recommended by the American Gastroenterological Association 5
PEG is preferred over surgical gastrostomy due to lower complication rates, reduced costs, and shorter procedure time, as recommended by the European Society for Clinical Nutrition and Metabolism 6, 7

Consider PEG with jejunal extension (PEG-J) or direct percutaneous endoscopic jejunostomy (PEJ) if gastroduodenal motility disorders are present, gastric outlet stenosis exists, high aspiration risk persists despite gastric feeding attempts, or severe delayed gastric emptying despite prokinetic therapy, as recommended by the American Gastroenterological Association and the European Society for Clinical Nutrition and Metabolism 5, 6